Carl Icahn

Illumina, Icahn prepare for proxy showdown
Illumina, Icahn prepare for proxy showdown
BioPharma Dive
Illumina
Carl Icahn
diagnostics
Medtech
Francis deSouza
Flag link:
Icahn wins proxy firm nod to oust CEO from Illumina board
Icahn wins proxy firm nod to oust CEO from Illumina board
Medtech Dive
Carl Icahn
Illumina
Francis deSouza
Medtech
Flag link:
Icahn pushes for spinoff of Illumina’s Grail division
Icahn pushes for spinoff of Illumina’s Grail division
BioPharma Dive
Illumina
Grail
Carl Icahn
M&A
spinoffs
Medtech
diagnostics
Flag link:
Why won’t Illumina sell Grail?
Why won’t Illumina sell Grail?
Medtech Dive
Illumina
M&A
Grail
Carl Icahn
Flag link:
Illumina urges shareholders to reject Carl Icahn’s board nominees as proxy fight heats up
Illumina urges shareholders to reject Carl Icahn’s board nominees as proxy fight heats up
CNBC
Illumina
Carl Icahn
Grail
M&A
Flag link:
Illumina, facing Icahn challenge, ‘moving quickly’ on resolution for Grail
Illumina, facing Icahn challenge, ‘moving quickly’ on resolution for Grail
BioPharma Dive
Illumina
Grail
M&A
Medtech
diagnostics
Carl Icahn
Flag link:
Illumina Responds to Icahn Partners' Nomination of Directors
Illumina Responds to Icahn Partners' Nomination of Directors
BioSpace
Illumina
Carl Icahn
M&A
Grail
Flag link:
Carl Icahn takes proxy fight to Illumina: report
Carl Icahn takes proxy fight to Illumina: report
Endpoints
Illumina
Grail
M&A
Carl Icahn
Flag link:
Icahn warns Cigna investors on Express Scripts deal
Icahn warns Cigna investors on Express Scripts deal
Yahoo/AP
Carl Icahn
Express Scripts
Cigna
Flag link:
Notorious activist investor Carl Icahn buys small stake in Allergan
Notorious activist investor Carl Icahn buys small stake in Allergan
Endpoints
Allergan
Carl Icahn
Flag link:
Icahn's (Potential) Move Into Biotech
Icahn's (Potential) Move Into Biotech
Yahoo/Benzinga
Carl Icahn
biotech
Flag link:
Icahn hires on gene therapy legend—and big biotech disruptor—Richard Mulligan as Bristol-Myers rumors simmer
Icahn hires on gene therapy legend—and big biotech disruptor—Richard Mulligan as Bristol-Myers rumors simmer
Endpoints
Carl Icahn
gene therapy
Richard Mulligan
Bristol-Myers Squibb
Flag link:
Icahn Takes Bristol-Myers Stake With M&A In Mind; Who Could Be The Acquirer?
Icahn Takes Bristol-Myers Stake With M&A In Mind; Who Could Be The Acquirer?
Yahoo/Benzinga
Bristol-Myers Squibb
M&A
Carl Icahn
Flag link:
Carl Icahn Bets Big on Allergan's CEO
Carl Icahn Bets Big on Allergan's CEO
Motley Fool
Carl Icahn
Allergan
Pharma CEOs
Brent Saunders
Flag link:
Allergan Stock Rises on Carl Icahn's Stake (AGN, PFE)
Allergan Stock Rises on Carl Icahn's Stake (AGN, PFE)
Investopedia
Allergan
Pfizer
Carl Icahn
Flag link:
Blacklisting Icahn: How Some Drug Companies Keep Out Activists
Blacklisting Icahn: How Some Drug Companies Keep Out Activists
Bloomberg
Carl Icahn
activists
Concordia
Mylan Labs
Endo International
Teva Pharmaceutical
Flag link:
A Deeper Look At Icahn's Vivus Play
A Deeper Look At Icahn's Vivus Play
Seeking Alpha
Carl Icahn
Vivus
Flag link:
Gilead Sciences (GILD) Stock Falls On Rumors Of Icahn’s Stake In The Company
Gilead Sciences (GILD) Stock Falls On Rumors Of Icahn’s Stake In The Company
Bidness Etc.
Gilead Sciences
Carl Icahn
Flag link:
Will Pharma's Future Be Based On The Carl Icahn Business Model?
Will Pharma's Future Be Based On The Carl Icahn Business Model?
Forbes
Carl Icahn
Actavis
Forest Labs
M&A
Flag link:
Forest Labs to add Icahn representative to board, avert proxy fight
Forest Labs to add Icahn representative to board, avert proxy fight
Reuters
Carl Icahn
Forest Labs
Flag link:

Pages